Text Size

General Practice Quality Assurance Project. Chronic Obstructive Pulmonary Disease (COPD) Diagnosis and Treatment

This study has been completed.
Sponsor:
Information provided by:
Boehringer Ingelheim Pharmaceuticals
ClinicalTrials.gov Identifier:
NCT00319813
First received: April 20, 2006
Last updated: April 15, 2008
Last verified: April 2008
History of Changes
  Purpose

A Cross sectional observational Quality Assurance Project in General Practice to COPD Diagnosis and Treatment


Condition Intervention Phase
Pulmonary Disease, Chronic Obstructive
 Behavioral: Education
 Phase 4

Study Type: Observational
Official Title: General Practice Quality Assurance Project. COPD Diagnosis and Treatment

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by Boehringer Ingelheim Pharmaceuticals:

Primary Outcome Measures:
  • To optimise the diagnosis and treatment of COPD via a quality assurance project
  • Increase the knowledge and use of diagnostic tools and treatment amongst PCPs
  • To focus on implementation of national guidelines for diagnosis and treatment of COPD

Estimated Enrollment: 8000
Estimated Study Completion Date: September 2007
  Eligibility

Ages Eligible for Study:   35 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • COPD patients over 35 years of age
  • More than two annual renewals with the following group of inhalation preparations: Anticholinergic, beta-2 antagonists, steroids or a combination of these

Exclusion Criteria:

  • Asthma
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00319813

Sponsors and Collaborators
Boehringer Ingelheim Pharmaceuticals
Investigators
Study Chair: Boehringer Ingelheim Study Coordinator B.I. Denmark A/S
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00319813     History of Changes
Obsolete Identifiers: NCT00479869
Other Study ID Numbers: 205.376
Study First Received: April 20, 2006
Last Updated: April 15, 2008
Health Authority: Denmark: Danish Dataprotection Agency

Additional relevant MeSH terms:
Chronic Disease
Lung Diseases
Respiration Disorders
Pulmonary Disease, Chronic Obstructive
 Lung Diseases, Obstructive
Disease Attributes
Pathologic Processes
Respiratory Tract Diseases

ClinicalTrials.gov processed this record on May 22, 2013